Amdocs (NASDAQ:DOX) Releases Q3 2026 Earnings Guidance

Amdocs (NASDAQ:DOXGet Free Report) issued an update on its third quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.810-1.870 for the period, compared to the consensus earnings per share estimate of 1.850. The company issued revenue guidance of $1.2 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. Amdocs also updated its FY 2026 guidance to 7.340-7.480 EPS.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on DOX shares. Barclays lowered their price objective on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, February 4th. Stifel Nicolaus set a $71.00 price target on Amdocs in a research note on Thursday. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Amdocs in a research note on Friday, May 8th. Finally, Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, April 18th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $86.67.

Read Our Latest Analysis on Amdocs

Amdocs Stock Down 3.9%

Shares of NASDAQ DOX opened at $59.93 on Thursday. The stock has a fifty day moving average price of $65.54 and a 200 day moving average price of $73.80. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23. Amdocs has a 12-month low of $59.40 and a 12-month high of $95.41. The company has a market cap of $6.47 billion, a P/E ratio of 11.59, a P/E/G ratio of 1.10 and a beta of 0.40.

Amdocs (NASDAQ:DOXGet Free Report) last announced its earnings results on Thursday, May 14th. The technology company reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.77 by $0.01. The business had revenue of $1.17 billion during the quarter, compared to the consensus estimate of $1.17 billion. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The business’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.78 earnings per share. Research analysts anticipate that Amdocs will post 6.64 EPS for the current fiscal year.

Amdocs Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be given a $0.569 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.8%. The ex-dividend date is Tuesday, June 30th. Amdocs’s dividend payout ratio (DPR) is presently 44.10%.

Key Headlines Impacting Amdocs

Here are the key news stories impacting Amdocs this week:

Institutional Trading of Amdocs

A number of large investors have recently modified their holdings of the company. EP Wealth Advisors LLC acquired a new stake in Amdocs in the 4th quarter valued at about $631,000. Mackenzie Financial Corp grew its holdings in shares of Amdocs by 218.0% during the 4th quarter. Mackenzie Financial Corp now owns 118,898 shares of the technology company’s stock valued at $9,644,000 after acquiring an additional 81,504 shares in the last quarter. NewEdge Advisors LLC increased its stake in shares of Amdocs by 8.6% in the fourth quarter. NewEdge Advisors LLC now owns 11,276 shares of the technology company’s stock worth $908,000 after acquiring an additional 897 shares during the last quarter. Empowered Funds LLC lifted its holdings in shares of Amdocs by 97.4% during the 4th quarter. Empowered Funds LLC now owns 41,466 shares of the technology company’s stock valued at $3,338,000 after buying an additional 20,460 shares during the last quarter. Finally, XTX Topco Ltd lifted its holdings in shares of Amdocs by 41.2% during the 4th quarter. XTX Topco Ltd now owns 14,183 shares of the technology company’s stock valued at $1,142,000 after buying an additional 4,139 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

About Amdocs

(Get Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Read More

Earnings History and Estimates for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.